| 英文别名 |
8-(3,5-DIFLUORO-4-(MORPHOLINOMETHYL)PHENYL)-2-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)QUINOXALINE DIHYDROCHLORIDE;C27H28F2N6O.2ClH;C27H28F2N6O.2HCl;BSK805;SYN1136;BCP23423;2606AH;s2686;BCP9001012;8-(3,5-difluoro-4-(morpholinomethyl)phenyl)-2-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxaline dihyd;NVP-BSK805 2HCl;NVP-BSK805 dihydrochloride;DA-47942;8-{3,5-Difluoro-4-[(morpholin-4-yl)methyl]phenyl}-2-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]quinoxaline--hydrogen chloride (1/2);8-[3,5-Difluoro-4-(4-morpholinylmethyl)phenyl]-2-[1-(4-piperidinyl)-1H-pyrazol-4-yl]quinoxaline dihydrochloride;DTXSID20720930;NVP-BSK805 2HCl (1092499-93-8 free base);NVP-BSK805 dihydrochloride;BSK805 dihydrochloride;NVPBSK805;NVP BSK805;NVP-BSK805;8-[3,5-difluoro-4-(morpholin-4-ylmethyl)phenyl]-2-[1-(piperidin-4-yl)pyrazol-4-yl]quinoxaline dihydrochloride;4-[[2,6-Difluoro-4-[3-(1-piperidin-4-ylpyrazol-4-yl)quinoxalin-5-yl]phenyl]methyl]morpholine dihydrochloride;1942919-79-0;NVP-BSK805/NVPBSK805;JAK2 inhibitor;NVP-BSK805 (dihydrochloride);GLXC-04410;4-(2,6-Difluoro-4-(3-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxalin-5-yl)benzyl)morpholine dihydrochloride;HY-14722A;SW219437-1;4-[[2,6-difluoro-4-[3-(1-piperidin-4-ylpyrazol-4-yl)quinoxalin-5-yl]phenyl]methyl]morpholine;dihydrochloride;AS-16275;NVP-BSK805 2HCl (BSK-805);CHEMBL4634656;EX-A4540;1092499-93-8 (free base);8-(3,5-difluoro-4-(morpholinomethyl)phenyl)-2-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)quinoxaline dihydr;CCG-264979;BCP0726000306;BSK 805;SCHEMBL23860571;NVP-BSK805 (hydrochloride);T6294;AKOS028109721;J-002254 |
在线客服
专业包装 品类齐全
厂家直发 快捷到货
品牌正品 质量保证
自助下单 尝选无忧
